CS logo
small CS logo
National Hospital Organization Iwakuni Clinical Center

Iwakuni, Yamaguchi, Japan
Medical center in Iwakuni
1 Chome-1-1 Atagomachi, Iwakuni, Yamaguchi 740-8510

About National Hospital Organization Iwakuni Clinical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Bayer
2
Chugai Pharmaceutical
2
Ministry of Health, Labour and Welfare, Japan
2
Total Rows: 4

Clinical Trials at National Hospital Organization Iwakuni Clinical Center


During the past decade, National Hospital Organization Iwakuni Clinical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22003311110000110000Started TrialsCompleted Trails2018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
2004-11-01
2006-03-01
Unknown status
1,500
Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
2005-06-01
2006-09-01
Completed
8
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
2018-06-15
2019-11-04
Completed
789
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)
2018-08-15
2021-07-08
Completed
1,026
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2020-09-30
2025-11-18
Active, not recruiting
1,074
Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)
2020-08-21
2023-08-16
Recruiting
1,200
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
2021-11-17
2026-12-29
Recruiting
690

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Iwakuni Clinical Center" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Mitsubishi Tanabe Pharma Corporation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJanssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Bayer: 2Bayer: 2Chugai Pharmaceutical: 2Chugai Pharmaceutical: 2Ministry of Health,Labour and Welfare,Japan: 2Ministry of Health,Labour and Welfare,Japan: 2

Created with Highcharts 11.1.0Top CollaboratorsJapan Lung Cancer Society: 2Japan Lung Cancer Society: 2Canadian VIGOUR Centre: 1Canadian VIGOUR Centre: 1Duke Clinical ResearchInstitute: 1Duke Clinical ResearchInstitute: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1Mitsubishi TanabePharma Corporation: 1Mitsubishi TanabePharma Corporation: 1

Clinical Trials Conditions at National Hospital Organization Iwakuni Clinical Center


According to Clinical.Site data, the most researched conditions in "National Hospital Organization Iwakuni Clinical Center" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Heparin-Induced Thrombocytopenia" (2 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials) and "Extensive Disease Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "National Hospital Organization Iwakuni Clinical Center" in a lesser frequency.

Clinical Trials Intervention Types at National Hospital Organization Iwakuni Clinical Center


Most popular intervention types in "National Hospital Organization Iwakuni Clinical Center" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lazertinib" (3 trials), "Placebo" (3 trials), "Amivantamab" (2 trials), "Amivantamab Intravenous" (1 trials) and "Amivantamab Subcutaneous and Co-Formulated with Recombinant Human Hyaluronidase (SC CF)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at National Hospital Organization Iwakuni Clinical Center


The vast majority of trials in "National Hospital Organization Iwakuni Clinical Center" are 9 trials for "All" genders.

Clinical Trials Status at National Hospital Organization Iwakuni Clinical Center


Currently, there are NaN active trials in "National Hospital Organization Iwakuni Clinical Center". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in National Hospital Organization Iwakuni Clinical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Iwakuni Clinical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Recruiting: 3Recruiting: 3Active, not recruiting: 2Active, not recruiting: 2Unknown status: 1Unknown status: 1